Medtech

Johnson & Johnson Medtech Partners with Qure.ai to Boost Early Detection of Lung Cancer in India 

This partnership embodies Johnson & Johnson MedTech's commitment to delivering life-saving innovations to healthcare providers...

SS Innovations to File FDA Application for Robotic Surgery System

SSi Mantra 3 robotic system moves toward FDA clearance for multispecialty use. ...

Avvio Medical Begins Clinical Trial for Innovative Kidney Stone Therapy

Enhanced Lithotripsy System (ELS) offers minimally invasive alternative to traditional surgical procedures ...

Imperative Care Enhances Stroke Treatment with Dual Aspiration Technology

Launch of Zoom DuoPort enables Continuous Dual Aspiration Technique (CDAT) for safer, faster procedures ...

Europe Embraces Health Data Sharing as Johnson & Johnson MedTech Survey Shows Rising Trust in Tech-Driven Care

Survey reveals strong public and professional confidence in digital health technologies to drive personalized treatment, surgical precision, and medical training across Europe....

CEO Bernd Montag Leads Siemens Healthineers Through Strong Q2 FY2025 Performance, Navigates Global Uncertainty with Strategic Caution

Under Montag’s leadership, the company reports 6.8% revenue growth and a 16.6% EBIT margin, while widening EPS guidance to address rising geopolitical and trade-related risks. ...

Leo Cancer Care’s Upright Particle Therapy System Marie Now 510(k) Pending

Marie® may soon become the first FDA-cleared upright particle therapy solution, aiming to reshape radiotherapy delivery across the U.S....

Angelini Ventures Co-Leads $45M Series B in Nuevocor to Advance Gene Therapy for Genetic Cardiomyopathy

Marking its first investment in Asia and the cardiovascular gene therapy space, Angelini Ventures backs Singapore-based Nuevocor to drive clinical development of NVC-001 for LMNA DCM....

RaySearch and Vision RT Integrate Surface Guidance into RayStation for Safer Radiotherapy Planning

ESTRO debut highlights breakthrough in collision-free, non-coplanar beam planning through surface-guided technology integration...

Peter Arduini Leads GE HealthCare Into FY25 With 51% Net Income Growth and $1B Share Repurchase Amid Global Uncertainty

With strong U.S. demand, a robust radiopharma rollout, and 4% organic revenue growth, CEO Peter Arduini highlights precision care strategy and innovation as GE HealthCare revises guidance under tariff pressures....